Aligos Therapeutics Forges Strategic Pevifoscorvir Sodium Licensing Pact with Xiamen Amoytop Biotech for Greater China Market
Aligos Therapeutics, a prominent clinical-stage biopharmaceutical company focused on developing novel therapeutics for liver diseases, has announced a significant exclusive...
July 26, 2025